PACB News and Press, Pacific Biosciences of California Inc. From 12/21/23

2023-12-21 14:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-12 14:16:54 ET Summary Illumina's market cap has fallen 80% from its all-time highs in 2021, but the divestment of Grail could bring it back on track. Illumina's competitive advantage lies in its scalable DNA sequencing platform and highly integrated system, which makes it...

PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors PR Newswire MENLO PARK, Calif. , Dec. 11, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today ...

2023-11-22 23:31:20 ET Summary ARK Genomic Revolution ETF focuses on genomic innovation in sectors such as healthcare, information technology, and energy. The fund's buying and selling activity gives us clues about the degrees of conviction relative to its main holdings. The f...

2023-11-21 22:50:51 ET Summary Pacific Biosciences of California is a biotechnology company specializing in genetic sequencing for healthcare, agriculture, and environmental science. PACB's acquisition of Apton Biosystems aims to integrate short-read technologies and capture a lar...

2023-11-20 22:03:46 ET Summary Pacific Biosciences reported a 72% YoY revenue growth in Q3 2023, driven by the successful launch of their Revio platform. The adoption of Revio by new customers and the potential to convert existing customers from Sequel II/IIe systems highlight the...

2023-11-17 09:25:41 ET More on Pacific Biosciences of California Pacific Biosciences of California, Inc. (PACB) Q3 2023 Earnings Call Transcript Pacific Biosciences: Looks Appealing In The Fast-Growing Long-Read Sequencing Market Pacific Biosciences of California Non...

2023-11-14 10:00:40 ET DENVER, Colo., Nov. 14, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; BioCardia Inc (NASDAQ: BCDA), INVO Bioscience Inc (NASDAQ: INVO), Theseus Pharmaceuticals Inc (NASDAQ: THRX),...

PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders PR Newswire Consortium Aims to Share Best Practices and Increase our Understanding of Genetic Disease MENLO PARK, Calif. , Nov. 2, 2023 /PRNewswire/ -- PacBio ...

PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible PR Newswire Partnerships Maximize Value of HiFi Data and Complete the Full End-to-End Workflow for PacBio Customers. MENLO PARK, Calif. , Nov. 1, 2023 ...